Bariatric Surgery Devices Market

The primary driver of the market is the rising prevalence of adult obesity and the increased operational effectiveness of cutting-edge robotic technologies. The (NICE) National Institute for Health and Care Excellence recommended that bariatric surgery be considered earlier for persons with diabetes mellitus than lifestyle changes and medication. In the upcoming years, these innovations are anticipated to accelerate market expansion. Additional projected market expansion drivers include expanding reimbursement coverage and sponsored bariatric procedures by regional governments of developed countries.

Intragastric balloons were added to the American Society for Metabolic and Bariatric Surgery's (ASMBS) list of suggested devices for use during bariatric surgeries in February 2018. Three of these devices were approved in Europe, and the FDA also approved these devices in the US in 2015–16. It is predicted that these endorsements and recommendations will significantly accelerate market expansion. Thus, this factor is driving the market CAGR.

An analysis of 2016 WHO data shows that 1.9 billion people are overweight, of which 650 million are obese. Around 13% of people over the age of 18 and 41 million children under the age of 5 are fat, according to statistics. The American Heart Association predicts that by 2030, the entire cost of medical care might increase to USD 957 billion from USD 861 billion. The government is acting to minimize the prevalence of obesity and its long-term chronic disorders because of the enormous healthcare spending.

The District of Columbia and 50 states received funding from the Centers for Disease Control and Prevention (CDC) in 2017 to improve initiatives. Thus, it is anticipated that this aspect will accelerate Bariatric Surgery Devices market revenue globally.

The increasing prevalence of obesity globally serves as a primary driver for the Global Bariatric Surgery Devices Market Industry. According to the World Health Organization, obesity rates have nearly tripled since 1975, with more than 1.9 billion adults classified as overweight. This alarming trend necessitates effective weight management solutions, leading to a growing demand for bariatric surgery devices. In 2024, the market is projected to reach 2.47 USD Billion, reflecting the urgent need for surgical interventions to combat obesity-related health issues. As awareness of obesity's health implications rises, the market is likely to expand further.

Technological innovations in bariatric surgery devices significantly enhance their effectiveness and safety, thereby propelling the Global Bariatric Surgery Devices Market Industry. Minimally invasive techniques, such as laparoscopic surgery, have gained traction, resulting in shorter recovery times and reduced complications. The introduction of advanced surgical instruments and robotic-assisted systems has further improved surgical outcomes. These advancements not only attract more patients but also encourage healthcare providers to adopt these technologies. As a result, the market is expected to grow, with projections indicating a rise to 4.75 USD Billion by 2035, driven by ongoing technological improvements.

The rising awareness and acceptance of bariatric surgery as a viable treatment option for obesity significantly influence the Global Bariatric Surgery Devices Market Industry. Educational campaigns and advocacy efforts by health organizations have helped to destigmatize surgical weight loss, encouraging individuals to consider surgical options. This shift in perception is crucial, as it leads to increased patient inquiries and consultations regarding bariatric procedures. As more patients seek surgical interventions, the market is poised for growth, with an anticipated increase in demand for various bariatric devices. This trend underscores the importance of education in driving market expansion.

Rising healthcare expenditure across various regions contributes to the growth of the Global Bariatric Surgery Devices Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes funding for obesity treatment programs. This trend is particularly evident in developed nations, where healthcare budgets are expanding to accommodate advanced surgical procedures. As healthcare systems allocate more resources to combat obesity, the demand for bariatric surgery devices is likely to increase. This financial commitment may lead to a compound annual growth rate of 6.13% from 2025 to 2035, reflecting the growing recognition of obesity as a critical public health issue.

Regulatory support and the establishment of guidelines for bariatric surgery play a pivotal role in shaping the Global Bariatric Surgery Devices Market Industry. Health authorities are increasingly recognizing the necessity of surgical interventions for obesity management, leading to the development of standardized protocols and approval processes for bariatric devices. This regulatory framework not only ensures patient safety but also fosters innovation within the industry. As regulatory bodies continue to endorse bariatric surgery, the market is likely to experience sustained growth, driven by the introduction of new devices and techniques that meet established safety and efficacy standards.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Bariatric Surgery Devices market accounted for USD 1.007 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The industry participants are conducting studies to assess the effectiveness of their surgeries to treat obesity due to rising obesity rates and significant government financing.

For instance, bariatric procedures previously covered by Medicare for people with BMIs of 40 or higher were changed to cover anyone with BMIs of 30 or higher. Many people who were fat and couldn't afford the high costs of surgery, doctors, and hospitals benefited from this development. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.

Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3 BARIATRIC SURGERY DEVICES MARKET SHARE BY REGION 2022 (%)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Bariatric Surgery Devices market accounts for the second-largest market share. Ireland leads the way in the frightening rise of obesity across Europe. The WHO study on the European Modelling Obesity Project detailed the different interventions and financial burdens on healthcare systems associated with obesity if it is not treated. As a result, the government is sponsoring numerous academic institutions to develop novel approaches. Moreover, UK market of Bariatric Surgery Devices held the largest market share, and the Germany market of Bariatric Surgery Devices was the fastest growing market in the region.

Asia Pacific Bariatric Surgery Devices Market is expected to grow at the fastest CAGR from 2022 to 2030. This can be attributed to many obese people and rising medical tourism due to surgery performed at reasonable prices. The Procedures, which cost USD 25,000 in the US, are available in Asia Pacific nations for USD 12,000. To examine the variables connected to obesity in this country, even industrial firms have expanded their research facilities there.

Further, the China market of Bariatric Surgery Devices held the largest market share, and the India market of Bariatric Surgery Devices was the fastest-growing market in the region.

Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of Bariatric Surgery Devices grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Bariatric Surgery Devices industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the  Bariatric Surgery Devices industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Bariatric Surgery Devices industry has provided medicine with some of the most significant benefits. The Bariatric Surgery Devices market major player such Medtronic, TransEnterix Surgical Inc., Johnson & Johnson Services Inc., Apollo Endosurgery Inc.,   ReShape Lifesciences Inc.

A clinical-stage medical device firm is GI Dynamics Inc. It is developing and marketing a medical device called EndoBarrier designed to treat people with type 2 diabetes and obesity. To explore end barrier-induced changes in bile acid, which regulates glucose and energy balance, GI Dynamics Inc. and GSK partnered.

A Johnson & Johnson subsidiary is Ethicon, Inc., which they acquired to broaden and diversify the Johnson & Johnson product portfolio; it was established as a distinct business under the Johnson & Johnson brand in 1949. Since 1887, Ethicon has been producing surgical sutures and tools for wound closure. Ethicon invested about $3.2 million. The money was spent researching how weight loss surgery affects Type 2 diabetes and obesity.